Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Strep A Translation

The Strep A Translation team aim to understand the epidemiology of Strep A infections in Australia and the world. Alongside this, they explore the implementation of endgame recommendations, health economics and new horizons.

The Strep A Translation team focuses on understanding disease burden and how to put evidence into action to make a difference.

Group A Streptococcus (Strep A) and rheumatic heart disease (RHD) research at The Kids is built around a focus on Indigenous leadership and collaboration, privileging the voices of those with lived experience of these diseases. Our Team provides the critical support to this approach.

The research and outputs of the Strep A Translation team have national and global focus, including:

  • Comprehensively documenting the burden and economic impacts of Strep A and RHD disease, and modelling the benefits of potential control strategies
  • Developing partnerships to translate evidence into tangible approaches to disease control, with a focus on policy, practice and community ownership
  • Fostering new research approaches including providing evidence around primordial prevention, particularly environmental health
  • Working with other research teams at The Kids to accelerate translation of evidence into impact, including developing a Strep A vaccine, a diagnostic test for rheumatic fever, and new strategies and formulations of penicillin to prevent RHD

Strep A Translation Global Collaboration Map

This map showcases our global partnerships, linking Australia with collaborators around the world who are working together to eliminate Strep A infections, and Rheumatic Heart Disease (RHD). Each connection represents a shared commitment to community-led research, cultural respect, and meaningful action.

From locally driven programs to international research collaborations, these connections highlight our collective commitment to equity in health and ending RHD worldwide.

Collaborators

Honoraries

Team leader

Professor Jonathan Carapetis AM
Professor Jonathan Carapetis AM

AM MBBS FRACP FAFPHM PhD FAHMS

Executive Director; Co-Head, Strep A Translation; Co-Founder of REACH

Associate Professor Glenn Pearson
Associate Professor Glenn Pearson

BA (Education) PhD Candidate

Director of First Nations Strategy and Leadership; Head, First Nations Health and Equity Research

Team members (14)

Program Manager END RHD

Jeffrey Cannon
Jeffrey Cannon

BSc(Hons) BBus PhD

Rosemary Wyber
Rosemary Wyber

MBChB MPH FRACGP PhD

Senior Research Fellow

Senior Research Fellow

Razieh Ahmady
Razieh Ahmady

Pharm.D, PhD

Senior Research Officer

Senior Project Coordinator

Program Coordinator

PhD Candidate and Research Assistant

Strep A Translation projects

Show more projects

Featured projects

Pacific Rheumatic Heart Disease (RHD) Program

The goal of the program is to establish the foundations of an effective, sustainable and equitable response to RHD in the Pacific.

Acute Rheumatic Fever Diagnosis Collaborative Network (ARC)

ARC is a global network of collaborators committed to reducing the burden of RHD in our lifetime.

Strep A Translation

Additional information

Reports and Findings

Show all

Missed Opportunities for Diagnosing Acute Rheumatic Fever

Topical antibiotics for chronic suppurative otitis media

Chronic suppurative otitis media (CSOM), sometimes referred to as chronic otitis media, is a chronic inflammation and often polymicrobial infection (involving more than one micro-organism) of the middle ear and mastoid cavity, characterised by ear discharge (otorrhoea) through a perforated tympanic membrane. The predominant symptoms are ear discharge and hearing loss.

What influences the implementation of health checks in the prevention and early detection of chronic diseases among Aboriginal and Torres Strait Islander people in Australian health care

Chronic disease is the leading cause of morbidity and mortality among Aboriginal and Torres Strait Islander peoples in Australia. A comprehensive health assessment is available as an annual health check (HC) to Aboriginal and Torres Strait Islander peoples through the Medicare Benefits Schedule in primary health care settings. This review aims to systematically identify contextual and mechanistic factors that contribute to the success or failure of implementing effective HCs in the prevention and early detection of chronic diseases among Aboriginal and Torres Strait Islander people in Australian primary health care (PHC).  

High dose, subcutaneous injections of benzathine penicillin G (SCIP) to prevent rheumatic fever: A single arm, phase IIa trial of safety and pharmacokinetics

This Phase-IIa trial evaluates the safety and pharmacokinetics of high-dose, 10 weekly subcutaneous injections of penicillin (SCIP) in young people with a history of acute rheumatic fever (ARF).

Show all